Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
NCT03757637 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380
Last updated 2024-04-19
Summary
Background: Despite the good prognosis of patients with differentiated thyroid carcinomas (DTC), the diagnosis of cancer, fear of cancer recurrence and its side effects might still bring impacts on patients' quality of life and daily function.
Purposes: This is a two-phase study. Phase I will aim to examine the current concerns of patients' physical-, psychological, care needs, and physical and psychological function in DTC patients within one year of diagnosis, and identify factors related to patients' physical and psychological functions. Phase II will be a three-group randomized control trail (RCT). The aims will be develop two intervention programs: Nurse-led Survivorship Care Program (NLSCP, Exp-1) and Information \& Communication Technology (ICT) Supported Healthy Active Program (ICT supported HAP, Exp-2), and compare the effects of the two intervention groups and control group of their effects on the variables in the above mentioned four dimensions (physical, psychological, care needs, function) in newly diagnosed DTC patients receiving total thyroidectomy.
Methods: Phase I is a cross-sectional survey study and to examine the current status of physical distress (e.g., fatigue, pain), psychological distress (e.g., depression, body-image), care needs, and psychological \& physical functions. Phase II is a 6-month three-group RCT with 12 month follow-up of its effects. There will have 5 intervention sections during the first 6 month. Control group will be case manager care only. The NLSCP will receive face-to-face or telephone education by trained nurse. The ICT supported HAP group will receive information or counseling through mobile phone App as the schedule intervention time. For both Exp groups, the first 2 sections of interventions will be all delivered face-to-face for helping them to be familiar with the operation system. Patients in the ICT supported HAP group can raise their concerns or questions through APP and receive intervention through App interactively. The outcomes will be assessed at 5 time points: time before first intervention (baseline assessment), 4-5 week before intervention, 3-, 6-, and 12 months.
Expected Outcome: We expect this study can help us better understanding DTC patients' impacts and care needs. The comparison of three groups of intervention will also help us to identify the best model to decrease distress and enhance life function for them.
Conditions
- Differentiated Thyroid Cancer
Interventions
- OTHER
-
NLSCP
Phase II is a 6-month three-group randomized controlled trial with 12 month follow-up of its effects. In addition to receive hospital routine case manager care, patients in this groups will further receive either NLSCP (Exp-1). Patients will be provided the same major education and counseling contents for the first two section of interventions through face-by-face by trained research nurses at time of (1) first intervention: one day before hospital discharge in post-operation, and (2) second intervention: first OPD visit (first week after hospital discharge). This group will receive a face-to-face education or counseling by trained research nurse.
- OTHER
-
ICT supported HAP
Phase II is a 6-month three-group randomized controlled trial with 12 month follow-up of its effects. In addition to receive hospital routine case manager care, patients in the groups will further receive ICT supported HAP (Exp-2) intervention. For this groups, patients will be provided the same major education and counseling contents for the first two section of interventions through face-by-face by trained research nurses at time of (1) first intervention: one day before hospital discharge in post-operation, and (2) second intervention: first OPD visit (first week after hospital discharge). The group will receive the interactive mobile phone App.
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Yeur-Hur Lai, Professor · School of Nursing, College of Medicine, National Taiwan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism
NCT02316743 ·Status: UNKNOWN ·Phase: PHASE4
-
Recovery Rate in Secondary Hypothyroidism
NCT05276856 ·Status: RECRUITING
-
HRQOL in Thyroid Cancer and Thyroid Tumours
NCT03676348 ·Status: RECRUITING
-
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01074684 ·Status: COMPLETED
-
Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer
NCT03469544 ·Status: UNKNOWN
-
Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer
NCT01840332 ·Status: COMPLETED ·Phase: NA
-
An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules
NCT01307761 ·Status: UNKNOWN
-
AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
NCT04463719 ·Status: COMPLETED ·Phase: NA
-
Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents
NCT06592118 ·Status: COMPLETED
-
Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma
NCT02689609 ·Status: COMPLETED
-
Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
NCT05510934 ·Status: RECRUITING
-
Anxiety & Depression in Thyroid Cancer Patients
NCT06269731 ·Status: NOT_YET_RECRUITING
-
Thyrotropin Over-suppression and Heart
NCT02645786 ·Status: COMPLETED
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Hyperthyroidism
NCT05675670 ·Status: UNKNOWN ·Phase: NA
-
Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
NCT07056218 ·Status: NOT_YET_RECRUITING
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
3D Thyroid Education Model for Student
NCT06147011 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT04857086 ·Status: UNKNOWN
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Circulating Biomarkers to Identify Thyroid Cancer
NCT04594720 ·Status: COMPLETED
-
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer
NCT01083550 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
NCT07124065 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer
NCT01744769 ·Status: UNKNOWN